rs773157352
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_021728.4(OTX2):c.226C>T(p.Arg76*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R76R) has been classified as Likely benign.
Frequency
Consequence
NM_021728.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- syndromic microphthalmia type 5Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Orphanet
- pituitary hormone deficiency, combined, 6Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- combined pituitary hormone deficiencies, genetic formInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated anophthalmia-microphthalmia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- patterned macular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- septooptic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.202C>T (p.R68*) alteration, located in exon 2 (coding exon 2) of the OTX2 gene, consists of a C to T substitution at nucleotide position 202. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 68. This alteration occurs in the last exon of the OTX2 gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 77% of the protein. Premature stop codons are typically deleterious in nature, the impacted region is critical for protein function, and a significant portion of the protein is affected (Ambry internal data). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
The R76X pathogenic variant in the OTX2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R76X variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R76X as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at